コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 use model of colonization resistance against Escherichia coli.
2 200 mRNAs per cell for exponentially growing Escherichia coli.
3 mental characteristic of bacteria other than Escherichia coli.
4 ast to be segregated before cell division in Escherichia coli.
5 B Streptococcus, Staphylococcus aureus, and Escherichia coli.
6 l role of ribosome recycling factor (RRF) in Escherichia coli.
7 ions on antibiotic resistance development in Escherichia coli.
8 he transcription of a Fur-controlled gene in Escherichia coli.
9 processing of the 3' end of the 16S rRNA in Escherichia coli.
10 ylanase, Xyl10E, was cloned and expressed in Escherichia coli.
11 as low a level of in vivo mistakes in RNA as Escherichia coli.
12 enomes and functionally characterize them in Escherichia coli.
13 rillum rubrum and Extraintestinal Pathogenic Escherichia coli.
14 l data of DNA polymerase I diffusing in live Escherichia coli.
15 ndCDE from Salmonella enterica and IscS from Escherichia coli.
16 with competing strains of S. Typhimurium and Escherichia coli.
17 d to enhance the antimicrobial resistance of Escherichia coli.
18 with meropenem to treat carbapenem-resistant Escherichia coli.
19 achinery that controls flagellar motility in Escherichia coli.
20 gineering of Azotobacter vinelandii NifEN in Escherichia coli.
22 ectron microscopy (cryo-EM) structure of the Escherichia coli 50S subunit at an average resolution of
24 nesis in tobacco correlated with assembly in Escherichia coli advocating use of this bacterium to pre
25 munized camel and purified the antibody from Escherichia coli after refolding it from inclusion bodie
26 interest in the structure and specificity of Escherichia coli AlkB and its homologs, difficulties in
27 oea associated with typical enteropathogenic Escherichia coli among children aged 6-11 months was 2.0
28 usters between 15 diverse species (including Escherichia coli and 12 rhizobia) help identify the barr
29 from cheese rind microbiomes on 2 bacteria (Escherichia coli and a cheese-isolated Pseudomonas psych
30 proposed SEF-AuNI sensors for model bacteria Escherichia coli and Bacillus subtilis can go to 0.5119
31 esent BEs that cause C-to-A transversions in Escherichia coli and C-to-G transversions in mammalian c
32 psis thaliana, Schizosaccharomyces pombe and Escherichia coli and how it can be used to study RBP dyn
33 Using tREX, we test 243 candidate tRNAs in Escherichia coli and identify 71 orthogonal tRNAs, cover
35 stinct plasmids in communities consisting of Escherichia coli and Klebsiella pneumoniae once antibiot
39 eria strains (including carbapenem-resistant Escherichia coli and methicillin-resistant Staphylococcu
40 nce-specific killing of carbapenem-resistant Escherichia coli and methicillin-resistant Staphylococcu
41 ic model of the fatty acid synthase (FAS) of Escherichia coli and paired that model with a fully reco
42 rs of the family, the transporters AmtB from Escherichia coli and Rh50 from Nitrosomonas europaea.
43 d BSA [AcBSA], zymosan, mannan, and LPS from Escherichia coli and Salmonella as well as to the monosa
47 factors and their target genes in pathogenic Escherichia coli and Salmonella revealed using chromatin
48 gle-cell lag times of populations of starved Escherichia coli and show that population growth after s
51 wo live bacterial strains: the Gram-negative Escherichia coli and the Gram-positive Bacillus subtilis
52 hese proteins were produced recombinantly in Escherichia coli and used as antigens in phage display s
53 -encoding plasmid was present in K. oxytoca, Escherichia coli, and Enterobacter cloacae isolates from
54 ium tuberculosis, Staphylococcus aureus, and Escherichia coli, and identify thousands of MGEs, includ
55 n of the sensor surface with polyclonal anti-Escherichia coli antibody allow to obtain high detection
58 positive Bacillus subtilis and Gram-negative Escherichia coli as model organisms to monitor bacterial
59 e (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacterial pathogens as well as with he
61 tenot et al. now show that Fur purified from Escherichia coli binds an all-Cys-coordinated [2Fe-2S] c
65 demonstrated Gram-negative activity against Escherichia coli BW25113, which is the first reported fo
66 dly, myristoylation efficiency of MA(NOS) in Escherichia coli by co-expressed mammalian NMT was reduc
67 in diameter) in the industrial microorganism Escherichia coli by expressing a set of carboxysome prot
68 on with the enteric pathogen enterotoxigenic Escherichia coli by maternal natural IgG antibodies agai
69 at its depletion attenuates the virulence of Escherichia coli by reducing levels of LPS and outer mem
73 ation factor antigen I (CFA/I) fimbriae from Escherichia coli can inhibit autoimmune diseases in muri
76 is class include M.EcoGII and M.EcoP15I from Escherichia coli, Caulobacter crescentus cell cycle-regu
78 cally active recombinant hGFAT2 (rhGFAT2) in Escherichia coli cells fused or not to a HisTag at the C
80 m of genetically modified Rosetta-gami B DE3 Escherichia coli cells, facilitating high-yield producti
81 ngle-cell measurements, we find that in live Escherichia coli cells, Zur's unbinding rate from DNA is
87 microscopy (cryo-EM) structures of an intact Escherichia coli class-II CAP-dependent transcription ac
88 ined high-resolution structures of wild-type Escherichia coli ClpAP undergoing active substrate unfol
89 to three published examples of multi-strain Escherichia coli communities with increasing complexity:
93 'gold-standard' is represented by infecting Escherichia coli cultures, followed by precipitation wit
96 gulation of gene expression by small RNAs in Escherichia coli depends on RNA binding proteins Hfq and
98 , consists of an RNA-guided Cas9 nickase, an Escherichia coli-derived uracil DNA N-glycosylase (eUNG)
100 hering of a protein of interest (POI) to the Escherichia coli DNA adenine methyltransferase (Dam).
101 entapeptide motif toward the beta subunit of Escherichia coli DNA polymerase III holoenzyme by mutati
103 We present the NMR solution structure for Escherichia coli DolP, which is composed of two BON doma
104 and DNA gap repair typically involve growing Escherichia coli (E coli) containing plasmids, followed
105 ofiles of sites of unsaturation of lipids in Escherichia coli (E. coli) and Acinetobacter baumannii (
106 vestigated the inactivation of Gram-negative Escherichia coli (E. coli) and Gram-positive Enterococcu
107 sed using the inhibition zone method against Escherichia coli (E. coli) and Staphylococcus aureus (S.
108 an in vivo assessment platform comprised of Escherichia coli (E. coli) and transgenic zebrafish embr
109 demonstrate rapid, sensitive and label-free Escherichia coli (E. coli) detection utilizing interfero
110 IEF-MS/MS identified 711 proteoforms from an Escherichia coli (E. coli) proteome consuming only nanog
113 Interacting Protein (DIP) Human, Drosophila, Escherichia coli (E. coli), and Caenorhabditis elegans (
115 modelling (FBA, pFBA, FVA and MOMA) and the Escherichia coli (E.coli) core stoichiometric model to i
117 ith the diarrheal pathogen enteroaggregative Escherichia coli (EAEC) is associated with growth falter
119 otypic multidrug (Mdr) transporter MdfA from Escherichia coli efflux chemically- dissimilar substrate
121 These observations were analogous to how Escherichia coli encountering cell stress and nutrient d
122 To address these challenges, we show that Escherichia coli Endonuclease V (eEndoV), an inosine-cle
124 d analysis of the three most common species, Escherichia coli, Enterococcus faecalis and Bacteroides
127 Recent efforts to develop an enterotoxigenic Escherichia coli (ETEC) vaccine have focused on the anti
130 ter-membrane porin (omp)-deficient strain of Escherichia coli expressing heterologous VcChiP could gr
132 ACPs in complex with the elongating KSs from Escherichia coli, FabF and FabB, in order to better unde
136 prisingly, recent single-cell experiments in Escherichia coli flagellar synthesis showed that flagell
138 ost well-studied of organisms, the bacterium Escherichia coli, for ~65% of promoters we remain ignora
140 no acid sequence identity, were expressed in Escherichia coli Functional characterization of the puri
143 fied evolutionarily conserved rare codons in Escherichia coli genes and associated such codons with c
147 he authors describe an elegant strategy that Escherichia coli has evolved to minimize metabolic stres
148 ol-Pal components to the cytokinetic ring in Escherichia coli has led to the proposal that the primar
149 ed from intestinal bacteria and expressed in Escherichia coli, has become commercially available.
150 ble for recycling peptidoglycan fragments in Escherichia coli, has not been annotated for most intrac
151 ere, we present the crystal structure of the Escherichia coli Hfq Core bound to a 30 bp DNA, containi
152 ine that the high-persister mutant strain of Escherichia coli, HipQ, is associated with the phenotype
153 itro impair P2 OLD-mediated killing of recBC-Escherichia coli hosts, indicating that both the ATPase
154 haride (LPS) and the Gram-negative bacterium Escherichia coli However, the physiological roles of TCP
155 microfluidic device to study thermotaxis of Escherichia coli in a broad range of thermal gradients w
156 tress, and contributes to gene expression in Escherichia coli In addition, Q8 was proposed to confer
157 th the prevalence of ciprofloxacin-resistant Escherichia coli in cattle and to determine if removal o
158 In 2015, the mcr-1 gene was discovered in Escherichia coli in domestic swine in China that conferr
159 ull-length human FMRP, FXR1P, and FXR2P from Escherichia coli in high yields, free of protein and nuc
161 We used a preclinical model of uropathogenic Escherichia coli-induced acute pyelonephritis to determi
170 hat is present in mycobacteria but absent in Escherichia coli, is required for the EsxA:B separation.
171 ned priority AMR phenotypes and genotypes of Escherichia coli isolated from the gastrointestinal trac
174 g Synechococcus elongatus with heterotrophic Escherichia coli K-12, Escherichia coli W, Yarrowia lipo
175 zed 48 RIBO-Seq samples from nine studies of Escherichia coli K12 grown in lysogeny broth medium and
178 mon alkylating agents to growing cultures of Escherichia coli leads to the accumulation of several ad
179 ssing three enzymes (almA, xylE, p450cam) in Escherichia coli led to degradation of 60-99% of target
180 necrosis factor-alpha (TNF-alpha), IL-1beta, Escherichia coli lipopolysaccharide (Ec-LPS) and Porphyr
181 vitro antimicrobial activity of CAR against Escherichia coli, Listeria monocytogenes, Salmonella ent
184 ous crystallographic studies have shown that Escherichia coli McrB uses a base-flipping mechanism to
187 Here we determine cryo-EM structures of Escherichia coli MlaFEDB in an apo state and bound to ph
188 ution digestions of proteomes extracted from Escherichia coli, mouse embryonic fibroblast cell cultur
189 ction is favored for C. crescentus MreB over Escherichia coli MreB because of a closer match in the d
190 s in the translation initiation step of many Escherichia coli mRNAs, particularly those with weak Shi
191 -R assay in Klebsiella pneumoniae (n = 236), Escherichia coli (n = 22), Enterobacter cloacae (n = 23)
192 o difference in the prevalence of pathogenic Escherichia coli, norovirus, or Giardia genes in the dom
193 ct substrate is especially difficult for the Escherichia coli Nudix hydrolase RppH, which triggers 5'
197 , breakpoints have been established only for Escherichia coli or Enterobacterales per the Clinical an
198 ally in classical bacteriophages that infect Escherichia coli or Salmonella, yet, less is known about
199 cal ligation and puncture or bacteremia with Escherichia coli or Streptococcus pneumoniae infection).
200 caecal ligation and puncture or infection by Escherichia coli or Streptococcus pneumoniae) and endoto
203 ve peptidoglycan precursors and fragments by Escherichia coli PBP1B, allowing us to (a) identify reco
204 19)F-(19)F nuclear Overhauser effects in the Escherichia coli peptidyl-prolyl cis/trans-isomerase B f
205 erminal domain is toxic when targeted to the Escherichia coli periplasm and that it depolarizes the c
206 r, we made the surprising discovery that the Escherichia coli periplasmic glycerol-3-phosphate (G3P)-
207 ng 10,000 compounds directly for stimulating Escherichia coli persister cell resuscitation, we identi
208 characterize host dependencies of two novel Escherichia coli phages, the T1-like siphophage LL5 and
211 bic growth on citrate (Cit(+)) evolved in an Escherichia coli population during adaptation to a minim
212 he "escape time" required for drug-resistant Escherichia coli populations to eclipse a threshold dens
213 eveal that colonization with curli-producing Escherichia coli promotes alphaSyn pathology in the gut
215 ntional 'on-bead' approach, we reconstituted Escherichia coli proteins MsbA and MscS and find that pe
216 ive organisms, including the human pathogens Escherichia coli, Pseudomonas aeruginosa, and Vibrio cho
217 erable 'all-in-one' vector was functional in Escherichia coli, Pseudomonas syringae and Klebsiella pn
218 AAE genes, expressed them heterologously in Escherichia coli, purified the corresponding recombinant
221 tein HU and on the ParB partition protein in Escherichia coli, revealing partially reversible dissoci
223 ilarly affect both the efficiency with which Escherichia coli RNA polymerase incorporates dinucleosid
224 to visualize seven intermediates containing Escherichia coli RNAP with the transcription factor TraR
225 , can stimulate translesion RNA synthesis by Escherichia coli RNAP without altering the fidelity of n
230 one due to neutropenic sepsis and one due to Escherichia coli sepsis), each in the setting of progres
233 ons of increased chromosome occupancy of the Escherichia coli SMC complex, MukBEF, the chromosome is
235 l inflammatory profile accounted for reduced Escherichia coli-specific responses in aged MAIT cells c
240 ssociated outbreaks of Shiga toxin-producing Escherichia coli (STEC) were first identified in 1991.
241 e finding that commensal bacteria, including Escherichia coli, stimulated HDAC activity through metab
244 rowth of the C. elegans dynamin mutant on an Escherichia coli strain with low vitamin B12 also strong
245 of febrile UTI is often caused by a virulent Escherichia coli strain, whereas recurrent infections an
246 e double-stranded DNA phages using two model Escherichia coli strains (K-12 and BL21) with known sequ
247 in vivo k (cat)s using metabolic specialist Escherichia coli strains that resulted from gene knockou
248 A library of recombinant non-pathogenic Escherichia coli strains was engineered to express seven
249 ation-enabled large-scale experiment wherein Escherichia coli strains were evolved in parallel after
250 rmine the antibiotic dose-response curves of Escherichia coli strains, and previous observations on a
253 sate consisting of heat-killed Gram-negative Escherichia coli Symbio and Gram-positive Enterococcus f
255 fitness effects of missense mutations in the Escherichia coli TEM-1 beta-lactamase antibiotic resista
257 n-mucin stain derived from enterohemorrhagic Escherichia coli that is tolerant to a wide range of gly
260 ve bioprocess using metabolically engineered Escherichia coli The pretreatment step achieved an almos
262 scharging is not known to occur in bacteria, Escherichia coli ThrRS also possesses robust cross-editi
265 n most studied species and R1-R2 octamers in Escherichia coli To better understand the distribution o
270 ts of transcript, protein and flux levels of Escherichia coli under various growth conditions as well
271 TPS1 and with a heterologous TPS (OtsA) from Escherichia coli, under the control of the TPS1 promoter
272 es are caused by Gram-negative uropathogenic Escherichia coli (UPEC) or Gram-positive Enterococcus fa
273 remove established biofilms of uropathogenic Escherichia coli (UPEC), Pseudomonas aeruginosa, and Sta
275 protein expressed in mammalian cells and in Escherichia coli using in vitro and in vivo methods.
277 . smegmatis, which possesses homologs of the Escherichia coli uvrA, uvrB, and uvrC genes, removes cyc
278 us with heterotrophic Escherichia coli K-12, Escherichia coli W, Yarrowia lipolytica, or Bacillus sub
281 charide synthesis, as has been suggested for Escherichia coli We find that ftsH interacts with divers
282 monas aeruginosa, Staphylococcus aureus, and Escherichia coli We have previously demonstrated that sp
283 genotypes in three distinct mRNA contexts in Escherichia coli We uncovered generic principles governi
284 tribution of the FinO-domain ProQ protein in Escherichia coli, we carried out RIL-seq to identify RNA
285 -canonical cross-links into the cell wall of Escherichia coli, we generated a bacterium where up to 3
286 tive guidelines for compound accumulation in Escherichia coli, we have converted the antibiotic Riboc
287 rary of the bla(ampC) beta-lactamase gene of Escherichia coli, we identified mutations that allow gro
288 monitoring of gene-copy-number mutations in Escherichia coli, we show that gene duplications and amp
293 ted, arsH1 and arsH2 genes were expressed in Escherichia coli, which has an endogenous arsRBC operon
294 into a Flux Balance Analysis (FBA) model of Escherichia coli, which quantitatively revealed potentia
295 anslocation of a gut-resident human pathogen Escherichia coli, which spreads systemically and caused
297 We experimentally evolved populations of Escherichia coli with genetically perturbed TMs for 1,00
298 from a biochemical analysis of the purified Escherichia coli YecSC-FliY cysteine/cystine import syst
299 tive Shigella species are close relatives of Escherichia coli, yet relatively few previously describe
300 some profiling analysis of phage T4-infected Escherichia coli yielded protected mRNA fragments within